Heldin CH - Search Results

1

Commercially Available Preparations of Recombinant Wnt3a Contain Non-Wnt Related Activities Which May Activate TGF-β Signaling.

Carthy JM, Engström U, Heldin CH, Moustakas A. Carthy JM, et al. Among authors: heldin ch. J Cell Biochem. 2016 Apr;117(4):938-45. doi: 10.1002/jcb.25378. Epub 2015 Sep 22. J Cell Biochem. 2016. PMID: 26369756

2

SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF beta-receptor.

Ekman S, Kallin A, Engström U, Heldin CH, Rönnstrand L. Ekman S, et al. Among authors: heldin ch. Oncogene. 2002 Mar 14;21(12):1870-5. doi: 10.1038/sj.onc.1205210. Oncogene. 2002. PMID: 11896619

3

Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation.

Moustakas A, Pardali K, Gaal A, Heldin CH. Moustakas A, et al. Among authors: heldin ch. Immunol Lett. 2002 Jun 3;82(1-2):85-91. doi: 10.1016/s0165-2478(02)00023-8. Immunol Lett. 2002. PMID: 12008039 Review.

4

From mono- to oligo-Smads: the heart of the matter in TGF-beta signal transduction.

Moustakas A, Heldin CH. Moustakas A, et al. Among authors: heldin ch. Genes Dev. 2002 Aug 1;16(15):1867-71. doi: 10.1101/gad.1016802. Genes Dev. 2002. PMID: 12154118 Free article. No abstract available.

5

TGF-beta signaling from a three-dimensional perspective: insight into selection of partners.

Souchelnytskyi S, Moustakas A, Heldin CH. Souchelnytskyi S, et al. Among authors: heldin ch. Trends Cell Biol. 2002 Jul;12(7):304-7. doi: 10.1016/s0962-8924(02)02300-0. Trends Cell Biol. 2002. PMID: 12185845

6

Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.

Yakymovych I, Engström U, Grimsby S, Heldin CH, Souchelnytskyi S. Yakymovych I, et al. Among authors: heldin ch. Biochemistry. 2002 Sep 10;41(36):11000-7. doi: 10.1021/bi025936u. Biochemistry. 2002. PMID: 12206672

7

Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.

Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P. Itoh S, et al. Among authors: heldin ch. J Biol Chem. 2003 Feb 7;278(6):3751-61. doi: 10.1074/jbc.M208258200. Epub 2002 Nov 22. J Biol Chem. 2003. PMID: 12446693 Free article.

8

Differential ubiquitination defines the functional status of the tumor suppressor Smad4.

Morén A, Hellman U, Inada Y, Imamura T, Heldin CH, Moustakas A. Morén A, et al. Among authors: heldin ch. J Biol Chem. 2003 Aug 29;278(35):33571-82. doi: 10.1074/jbc.M300159200. Epub 2003 Jun 5. J Biol Chem. 2003. PMID: 12794086 Free article.

9

Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.

Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P, Heldin CH, Ericsson J, Moustakas A. Kurisaki K, et al. Among authors: heldin ch. Mol Cell Biol. 2003 Jul;23(13):4494-510. doi: 10.1128/MCB.23.13.4494-4510.2003. Mol Cell Biol. 2003. PMID: 12808092 Free PMC article.

10

The nuts and bolts of IRF structure.

Moustakas A, Heldin CH. Moustakas A, et al. Among authors: heldin ch. Nat Struct Biol. 2003 Nov;10(11):874-6. doi: 10.1038/nsb1103-874. Nat Struct Biol. 2003. PMID: 14583734 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters